Butagran Equi 200 mg/g Oral powder
Butagran Equi 200 mg/g Oral powder
Awtorizzat
- Phenylbutazone
Identifikazzjoni tal-prodott
Isem tal-mediċina:
Butagran Equi 200 mg/g Oral powder
Butagran Equi, 200 mg/g, geriamieji milteliai arkliams
Sustanza attiva:
- Disponibbli biss fi English
Metodu ta’ amministrazzjoni:
-
Użu orali
Dettalji tal-prodott
Sustanza attiva / Qawwa:
-
Disponibbli biss fi English200.00milligram(s)1.00gram(s)
Forma farmaċewtika:
-
Trab orali
Withdrawal period by route of administration:
-
Użu orali
- Horse
-
Meat and offalno withdrawal periodNot for use in horses intended for human consumption. Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation.
-
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
- QM01AA01
Status tal-awtorizzazzjoni:
-
Valid
Tagħrif addizzjonali
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
- Dopharma Research B.V.
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
- Dopharma Research B.V.
Awtorità responsabbli:
- State Food And Veterinary Service
Numru tal-awtorizzazzjoni:
- LT/2/13/2151/001-004
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Numru tal-proċedura:
- BE/V/0035/001
Stati Membri Kkonċernati:
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Dokumenti
RV2151.pdf
Lithuanian (PDF)
Niżżel Ippubblikat fuq: 30/05/2022
Kemm kienet utli din il-paġna?: